Cargando…
Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317808/ https://www.ncbi.nlm.nih.gov/pubmed/34337547 http://dx.doi.org/10.1016/j.euros.2021.06.006 |
| _version_ | 1783730124768673792 |
|---|---|
| author | Kartolo, Adi Procopio, Giuseppe Vera-Badillo, Francisco E. |
| author_facet | Kartolo, Adi Procopio, Giuseppe Vera-Badillo, Francisco E. |
| author_sort | Kartolo, Adi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8317808 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83178082021-07-29 Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? Kartolo, Adi Procopio, Giuseppe Vera-Badillo, Francisco E. Eur Urol Open Sci Opinion: Open Science Elsevier 2021-06-26 /pmc/articles/PMC8317808/ /pubmed/34337547 http://dx.doi.org/10.1016/j.euros.2021.06.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Opinion: Open Science Kartolo, Adi Procopio, Giuseppe Vera-Badillo, Francisco E. Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title | Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title_full | Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title_fullStr | Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title_full_unstemmed | Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title_short | Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer? |
| title_sort | management of favorable-risk advanced renal cell carcinoma: is dual therapy the answer? |
| topic | Opinion: Open Science |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317808/ https://www.ncbi.nlm.nih.gov/pubmed/34337547 http://dx.doi.org/10.1016/j.euros.2021.06.006 |
| work_keys_str_mv | AT kartoloadi managementoffavorableriskadvancedrenalcellcarcinomaisdualtherapytheanswer AT procopiogiuseppe managementoffavorableriskadvancedrenalcellcarcinomaisdualtherapytheanswer AT verabadillofranciscoe managementoffavorableriskadvancedrenalcellcarcinomaisdualtherapytheanswer |